Novavax, Inc.
USD10.20
-0.01 (-0.10%)
CEO
John Charles Jacobs
IPO Date
1995-12-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.11
Prev. Close
$10.21
Day Low
$9.94
Day High
$10.31
52W Low
$6.13
52W High
$11.97
Market Cap
$1.68B
Volume
3.07M
| 9,520 |
| $0.00 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | A-Award | Acquired | 99,500 | $8.46 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | A-Award | Acquired | 66,000 | $0.00 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | Disposed | 0 | $0.00 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | Disposed | 11,500 | $6.97 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | Disposed | 26,300 | $0.00 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | Disposed | 22,510 | $10.11 |
| 16 Apr 2026 | Walker Robert Edward | EVP, R&D | Disposed | 18,826 | $8.39 |
| 12 Mar 2026 | Shiver John W. | director | M-Exempt | Acquired | 7,947 | $0.00 |